ArteryFlow Technology is a pioneer in the intelligent diagnosis and treatment planning of cardiovascular and cerebrovascular diseases. Established in 2017, the company is headquartered in Hangzhou, China. With the slogan "Bringing Precision to Medicine," ArteryFlow Technology specializes in providing precise and personalized diagnosis and treatment planning for cardiovascular and cerebrovascular diseases. Leveraging deep technical accumulation in computing simulation, artificial intelligence, and medical imaging processing, the company offers comprehensive solutions covering intelligent screening, detection, diagnosis, and surgical planning for patients with cardiovascular and cerebrovascular diseases in hospitals, imaging centers, and medical examination centers. Their innovative approach aims to deliver a better experience for both patients and clinicians. With a focus on the Health Care and Manufacturing industries, ArteryFlow Technology stands out as a promising player in the field of medical technology innovation. While specific details about the last investment and investors are not currently available, the company's strategic positioning and innovative solutions make it an intriguing prospect for potential investors in the healthcare technology sector.
There is no investment information
No recent news or press coverage available for ArteryFlow Technology.